Astria Therapeutics (ATXS) Non-cash Items: 2017-2019
Historic Non-cash Items for Astria Therapeutics (ATXS) over the last 3 years, with Sep 2019 value amounting to $352,000.
- Astria Therapeutics' Non-cash Items rose 245.10% to $352,000 in Q3 2019 from the same period last year, while for Sep 2019 it was $352,000, marking a year-over-year increase of 245.10%. This contributed to the annual value of $2.3 million for FY2018, which is 964.81% up from last year.
- Per Astria Therapeutics' latest filing, its Non-cash Items stood at $352,000 for Q3 2019, which was down 75.23% from $1.4 million recorded in Q2 2019.
- Over the past 5 years, Astria Therapeutics' Non-cash Items peaked at $2.7 million during Q2 2018, and registered a low of $102,000 during Q3 2018.
- For the 3-year period, Astria Therapeutics' Non-cash Items averaged around $970,636, with its median value being $817,000 (2017).
- The largest annual percentage gain for Astria Therapeutics' Non-cash Items in the last 5 years was 1,842.45% (2018), contrasted with its biggest fall of 87.52% (2018).
- Astria Therapeutics' Non-cash Items (Quarterly) stood at $216,000 in 2017, then skyrocketed by 964.81% to $2.3 million in 2018, then spiked by 245.10% to $352,000 in 2019.
- Its Non-cash Items was $352,000 in Q3 2019, compared to $1.4 million in Q2 2019 and $1.3 million in Q1 2019.